Open Access[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]
Author(s) -
Lorenzo Pradelli,
Paolo A. Ascierto
Publication year - 2017
Publication title -
farmeconomia/farmeconomia e percorsi terapeutici
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v18i1.1329
Subject(s) - dabrafenib , trametinib , melanoma , medicine , cancer research , metastatic melanoma , biology , vemurafenib , mapk/erk pathway , kinase , microbiology and biotechnology